How to Help Your Patients Save Money on Pancreaze: A Provider's Guide to Savings Programs

For prescribers managing patients with exocrine pancreatic insufficiency (EPI), cost is a significant barrier to medication adherence. Pancreaze (pancrelipase, VIVUS LLC) is a brand-name medication with no FDA-approved generic — retail prices can range from under $100 to over $1,500 per 100-capsule supply depending on strength, making it one of the more expensive maintenance medications for patients without robust insurance coverage.

Because EPI patients take Pancreaze with every meal and snack — often 3–6 times per day — even patients with insurance can face meaningful out-of-pocket costs. This guide provides a comprehensive overview of available savings resources and practical strategies for providers to help patients access Pancreaze affordably in 2026.

Understanding the Cost Landscape for Pancreaze

As of 2026, Pancreaze is covered on approximately 81% of commercial insurance plans, with some plans requiring prior authorization. Coverage tier varies — Pancreaze may be listed as Tier 2 on some plans and Tier 3 (specialty) on others. Key cost drivers include:

• Brand-only market: No generic pancrelipase product exists or is expected in the near term.
• High daily consumption: Patients taking 3+ capsules per meal with 3 meals and 2 snacks may use 9–15 capsules per day (270–450 capsules per month).
• Strength variation: Higher-strength capsules cost significantly more — the 37,000 unit capsule retails at over $1,570 per 100 caps vs. ~$93 for the 2,600 unit strength.

Program 1: Pancreaze Savings Card — Enhanced Benefits as of February 2026

As of February 1, 2026, VIVUS updated the Pancreaze Savings Card with enhanced benefits. This is the primary tool for commercially insured patients:

• Benefit: Up to $2,000 off co-pay or out-of-pocket per prescription fill; maximum yearly benefit of $3,500
• Eligible patients may pay: As little as $0 per fill
• Eligibility: Commercially insured patients only. Excludes Medicare, Medicaid, TRICARE, VA, DOD, and Medigap.
• How to access: pancreaze.com/savings-and-support or call 1-888-238-8059

Clinical implication: For commercially insured patients, the Pancreaze Savings Card can reduce patient burden to near-zero. Ensure your office staff or your prescriber's portal prompts enrollment for all newly prescribed commercial patients.

Program 2: Pancreaze Patient Assistance Program (PAP)

For uninsured or underinsured patients, VIVUS offers a Patient Assistance Program that can provide Pancreaze at no cost for eligible patients. Eligibility criteria:

• U.S. resident treated by a U.S.-licensed healthcare provider as an outpatient
• Household income at or below 300% of the Federal Poverty Guidelines
• Patient spends 4% or more of gross annual income on prescription drugs
• No insurance, or insurance does not cover the medication
• Note: Medicare Part D patients who meet financial criteria may also qualify

Contact: 1-855-751-5540 | pancreazeadvantage.com. Providers must help patients complete the application — ensure your staff knows how to access and submit the paperwork.

Program 3: HealthWell Foundation — Cystic Fibrosis Fund

For patients with cystic fibrosis who have insurance but face high out-of-pocket costs, the HealthWell Foundation's Cystic Fibrosis Fund provides copay assistance:

• Phone: 1-800-675-8416 | healthwellfoundation.org/cystic-fibrosis
• Requires: Valid prescription, proof of household income, insurance coverage
• Pediatric assistance is also available

HealthWell grants are limited and subject to fund availability. For CF patients with insurance, this program should be explored alongside the manufacturer savings card.

Insurance Navigation Strategies for Prescribers

When Pancreaze is not covered or faces high-tier status on a patient's plan, providers can take several advocacy steps:

• Prior authorization support: Document the patient's diagnosis (EPI, specific etiology), failed or contraindicated alternatives, and clinical necessity. Pancreaze's phthalate-free formulation may be a clinically relevant differentiator in PA appeals for patients who require it.
• Step therapy exceptions: If a plan requires trying another PERT before covering Pancreaze, document specific clinical reasons (patient intolerance to alternative, dosing requirements, prior therapeutic failure) to support a step therapy exception.
• 90-day supply prescriptions: Where plan benefits allow, prescribing a 90-day supply through mail-order can reduce cost per unit for the patient and simplify access logistics.
• Annual plan review: During open enrollment, advise patients to check their plan's coverage for Pancreaze specifically, as formulary placements change annually. The difference in annual out-of-pocket can be thousands of dollars between plans.

Third-Party Discount Programs

For patients who are ineligible for manufacturer programs (typically Medicare patients not qualifying for PAP), third-party discount programs can help:

• GoodRx Gold: Pricing as low as $140.29 per fill for certain Pancreaze strengths — most useful for uninsured patients or those in high-deductible plan deductible phases.
• SingleCare and RxSaver: Additional coupon programs that may offer competitive pricing at specific pharmacy chains.

Important note: Patients cannot use insurance AND a GoodRx coupon at the same time. Advise patients to compare their insurance copay to the GoodRx price at each fill — whichever is lower should be used.

Incorporating Savings Counseling into Your Practice Workflow

Consider adding financial counseling for Pancreaze as a standard component of new EPI patient onboarding:

1. At first prescription: Enroll commercially insured patients in the Pancreaze Savings Card.
2. At first prescription for uninsured/underinsured: Begin PAP application with the patient or refer to a social worker.
3. For CF patients: Check HealthWell Foundation eligibility.
4. At follow-up visits: Verify the patient is still enrolled in their savings program and has not had changes in insurance status that affect eligibility.
5. Consider prescribing 90-day supplies through mail order to reduce cost-per-dose and improve adherence.

For guidance on helping patients access Pancreaze when it's hard to find at their pharmacy, see our companion provider resource: How to Help Your Patients Find Pancreaze in Stock: A Provider's Guide.

At medfinder, we support providers in helping their patients access medications. When your patients are both managing costs and struggling to find Pancreaze in stock, medfinder can help them locate pharmacies that carry their specific strength.